Distillate Capital Partners LLC Horizon Therapeutics Public LTD CO Transaction History

Distillate Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $4.79 Million - $8.73 Million	-76,750 Reduced 99.8%	153 $17.4 Million
Q3 2022 Nov 09, 2022	BUY	$58.92 - $84.67 $872,958 - $1.25 Million	14,816 Added 23.86%	76,903 $4.91 Million
Q2 2022 Aug 03, 2022	BUY	$79.4 - $116.36 $751,282 - $1.1 Million	9,462 Added 17.98%	62,087 $4.95 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $1.32 Million - $1.67 Million	15,227 Added 40.72%	52,625 $5.54 Million
Q4 2021 Feb 08, 2022	BUY	$98.56 - $119.91 $590,177 - $718,021	5,988 Added 19.06%	37,398 $4.03 Million
Q3 2021 Nov 05, 2021	BUY	$91.91 - $110.37 $269,296 - $323,384	2,930 Added 10.29%	31,410 $3.44 Million
Q2 2021 Jul 30, 2021	BUY	$86.24 - $95.92 $2.46 Million - $2.73 Million	28,480 New	28,480 $2.67 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Distillate Capital Partners LLC with notifications on news.